Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
Genmab A/S (GNMSF) had Earnings per Share (EPS) (Diluted) of $0.83 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$896.00M |
|
$53.00M |
|
$65.00M |
|
$831.00M |
|
$716.00M |
|
$180.00M |
|
$-106.00M |
|
$74.00M |
|
$74.00M |
|
$53.00M |
|
$53.00M |
|
$53.00M |
|
$53.00M |
|
$180.00M |
|
$209.00M |
|
63.09M |
|
63.85M |
|
$0.84 |
|
|
Earnings per Share (EPS) (Diluted) |
$0.83 |
| Balance Sheet Financials | |
$2.57B |
|
$143.00M |
|
$9.80B |
|
$12.38B |
|
$1.18B |
|
$4.93B |
|
$5.52B |
|
$6.69B |
|
$5.68B |
|
$-3.62B |
|
$5.68B |
|
64.24M |
|
| Cash Flow Statement Financials | |
$3.00M |
|
$-9.00M |
|
$-177.00M |
|
$1.72B |
|
$1.52B |
|
$-194.00M |
|
$49.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.18 |
|
-- |
|
-- |
|
0.46 |
|
0.92 |
|
92.75% |
|
20.09% |
|
20.09% |
|
-- |
|
8.26% |
|
5.92% |
|
$-2.00M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
3.10 |
|
0.87 |
|
103.56 |
|
0.93% |
|
-1.46% |
|
0.43% |
|
0.50% |
|
$88.45 |
|
$-0.03 |
|
$0.05 |
|